CRYSTALLO-CO-AGGLOMERATION OF SIMVASTATIN: IMPROVING DISSOLUTION AND MICROMERITIC PROPERTIES

Authors

  • Indra Indra Universitas Bakti Tunas Husada Tasikmalaya https://orcid.org/0000-0002-2560-1190
  • Gustania Intan Indriani Prodi Farmasi, Fakultas Farmasi, Universitas Bakti Tunas Husada, Tasikmalaya, Indonesia
  • Tuslinah Lilis Prodi Farmasi, Fakultas Farmasi, Universitas Bakti Tunas Husada, Tasikmalaya, Indonesia

DOI:

https://doi.org/10.36423/pharmacoscript.v7i2.1679

Keywords:

Simvastatin, crystallo-co-agglomeration, dissolution rate, micromeritic properties

Abstract

Simvastatin (SMV), a poorly soluble drug, faces challenges in pharmaceutical formulation due to its limited solubility and poor flow properties. This study aimed to enhance the physicochemical properties of SMV by preparing spherical crystals using a crystallo-co-agglomeration. Spherical crystals of SMV were prepared by dissolving the drug in methanol and adding it to an aqueous solution containing PVP K-30 and PEG 6000 under constant stirring. The resulting agglomerates were filtered, dried, and characterized using Fourier Transform Infrared (FTIR) spectroscopy, Powder X-Ray Diffraction (PXRD), Differential Scanning Calorimetry (DSC), Scanning Electron Microscopy (SEM), and dissolution testing. Micromeritic properties, including bulk density, Hausner ratio, compressibility index, angle of repose, and flowability, were also evaluated. FTIR confirmed the chemical integrity of SMV with minor shifts indicating interactions with stabilizers. PXRD and DSC analyses revealed reduced crystallinity and partial amorphization in the spherical crystals. SEM showed spherical morphology. Dissolution testing demonstrated a significantly enhanced dissolution rate for the spherical crystals compared to pure SMV. Improved micromeritic properties were also observed, indicating better flowability and packing density. Spherical crystallization significantly improved the solubility, dissolution rate, and flowability of SMV. This technique offers a promising strategy for enhancing the bioavailability and pharmaceutical performance of poorly soluble drugs.

References

Abdullahi, A. K., Olowosulu, A. K., & Allagh, T. S. (2023). Crystallo-co-Agglomeration Technique for Improving Physicochemical Properties, Compressibility and Solubility Characteristics of Metronidazole. British Journal of Pharmacy, 8(1). https://doi.org/10.5920/bjpharm.1039

Chatterjee, A., Gupta, M. M., & Srivastava, B. (2017). Spherical Crystallization: A Technique Use to Reform Solubility and Flow Property of Active Pharmaceutical Ingredients. International Journal of Pharmaceutical Investigation, 7(1), 4. https://doi.org/10.4103/jphi.jphi_36_16

Dalvadi, H., Parmar, K., & Yadav, S. (2019). Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide. Drug Development and Industrial Pharmacy, 45(6), 968–980. https://doi.org/10.1080/03639045.2019.1585447

Elkadi, S., Elsamaligy, S., Al-Suwayeh, S., & Mahmoud, H. (2017). The Development of Self-nanoemulsifying Liquisolid Tablets to Improve the Dissolution of Simvastatin. AAPS PharmSciTech, 18(7), 2586–2597. https://doi.org/10.1208/s12249-017-0743-z

Flouda, K., Qiu, D., & Tsolakou, T. (2014). The Influence of Pressure on the Intrinsic Dissolution Rate of Amorphous Indomethacin. 481–493. https://doi.org/10.3390/pharmaceutics6030481

Garala, K. C., Patel, J. M., Dhingani, A. P., & Dharamsi, A. T. (2013). Preparation and evaluation of agglomerated crystals by crystallo-co- agglomeration: An integrated approach of principal component analysis and Box-Behnken experimental design. International Journal of Pharmaceutics, 452(1–2), 135–156. https://doi.org/10.1016/j.ijpharm.2013.04.073

Hansen, J., & Kleinebudde, P. (2021). Enabling the direct compression of metformin hydrochloride through QESD crystallization. International Journal of Pharmaceutics, 605(March), 120796. https://doi.org/10.1016/j.ijpharm.2021.120796

Kementerian Kesehatan Republik Indonesia. (2020). Farmakope Indonesia edisi VI. In Kementerian Kesehatan Republik Indonesia.

Kim, K.-H., Park, J.-B., Choi, W.-J., Lee, H.-S., & Kang, C.-Y. (2011). Preparation and Characterization of Simvastatin Solid Dispersion using Aqueous Solvent. Journal of Pharmaceutical Investigation, 41(4), 239–247. https://doi.org/10.4333/kps.2011.41.4.239

Knopp, M. M., Wendelboe, J., Holm, R., & Rades, T. (2018). Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion. European Journal of Pharmaceutics and Biopharmaceutics, 130(May), 290–295. https://doi.org/10.1016/j.ejpb.2018.07.005

Downloads

Published

2024-08-08

Issue

Vol. 7 No. 2 (2024): Pharmacoscript

Section

Articles

License

Copyright (c) 2024 Indra Indra, Intan Indriani Gustania, Lilis Tuslinah

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication, with the work [SPECIFY PERIOD OF TIME] after publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).